This session recorded on 6 March 2024, will provide evidence and guidance on the use of melatonin in children based on recent comprehensive review by melatonin task force of the International Pediatric Sleep Association with an upcoming position statement. In addition, preliminary findings from an Australian study will be delivered. Finally, case-based scenarios will be used to stimulate discussion about what families are reading on media coverage and professional organizations are advising.

Melatonin use has increased exponentially in the last few years both in neurodiverse children and typically developing children to assist with sleep difficulties. This is both through increased prescribing from medical primary and tertiary care professionals but also through online access for parents from overseas less regulated markets.

This webinar recorded on 6 March 2024, will provide evidence and guidance on the use of melatonin in children based on recent comprehensive review by melatonin task force of the International Pediatric Sleep Association with an upcoming position statement. In addition, preliminary findings from an Australian study will be delivered. Finally, case-based scenarios will be used to stimulate discussion about what families are reading on media coverage and professional organizations are advising.

This webinar is free for members and $10 for non-members.

• Training Hours: 1.00